Showing: 254 Results
Events

Ask us anything | Wednesday, September 1, 2021

The SIU Family Medicine Residency Program, Alton is happy to offer some upcoming residency program informational sessions via Webex. Please join us for these 30-minute sessions to get your questions answered! Each session with begin with a short presentation of general program information and we will then open the session to attendees for questions. Please note that these sessions are not practice interview opportunities. Be prepared to arrive to the session(s) of your choice on time to ensure you hear the entire presentation and don’t miss any information. Wednesday, September 1, 2021 – 8
Trial
Simmons Cancer Institute

ASND0029 "IL Believe": A Phase 1/2, Open-label, Dose Escalation and Dose Expansion Study to Investigate the Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab, TransCon TLR7/8 Agonist, or Other Anticancer Therapies, in

Active recruiting

This study is investigating experimental drugs TransCon IL-2 β/γ and TransCon TLR7/8 for the treatment of a

Contact: Kathy Robinson 217-545-1946
Trial
Vascular Surgery

Assessment of the GORE® EXCLUDER® Conformable AAA Endoprosthesis in the Treatment of Abdominal Aortic Aneurysms: AAA 13-03

Active not recruiting

The purpose of this study is to assess the safety and effectiveness of the GORE® EXCLUDER® Conformable AAA Endoprosthesis (Study Device) when used for the treatment of Abdominal Aortic Aneurysms (AAA).

Contact: Kristal Adams 217-545-7812
Trial
Internal Medicine

AstraZeneca BaxHTN: A Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Efficacy and Safety of Baxdrostat in Participants With Uncontrolled Hypertension on Two or More Medications Including Participants With Resistant Hypert

Active not recruiting

The purpose of this clinical trial is to trial is to learn more about a new, investigational, once daily medication, called baxdrostat, and its ability to lower blood pressure in individuals not responding to their current treatment.

Contact: Emily Starkey 217-545-7616
Trial
Simmons Cancer Institute

BC-IMT-04: Randomized, Open-Label Study of the Bria-IMT Regimen and Check Point Inhibitor vs Physicians' Choice in Advanced Metastatic Breast Cancer (BRIA-ABC)

Active recruiting

This is a multicenter randomized, open label study to evaluate overall survival with the Bria-IMT regimen in combination with Checkpoint Inhibitor [Retifanlimab], versus Treatment of Patients'/Physicians' Choice (TPC) in advanced metastatic or locally recurrent breast cancer (aMBC) patients with no approved alternative therapies available.

Contact: Kathy Robinson 217-545-1946
Trial
Obstetrics and Gynecology

Biomarkers for Endometrial and Ovarian Cancer

Active recruiting

PURPOSE: This is a biological sample collection study aimed at developing an early diagnostic tool for endometrial and ovarian cancer. The investigators are studying the relationship between estrogen driven gynecological cancers, inflammation and the microbiome. Patients who have been diagnosed with endometrial cancer or undergo presurgical evaluation for suspicion of ovarian cancer who are scheduled for a hysterectomy, bilateral oophorectomy and/or salpingectomy are eligible. Control patients undergoing gynecological surgery for benign indications are also being recruited.

Contact: Kathleen Groesch 217-545-6671
Events

Brain Aging Conference - Community Day

The Brain Aging Conference - Community Day is open to the public, providing the latest information on research, treatment, care and quality of life for persons with dementia and their care partners. Hosted at the Memorial Learning Center, attendees will have a chance to hear from medical professionals from the Smith Alzheimer's Center, other institutions, experienced caregivers, as well as a chance to connect with area organizations offering helpful resources. There is no fee to register, but advanced registration is required to attend. Lunch will be provided for attendees. If you would like
Events

Brain Aging Conference - Community Day

The Brain Aging Conference - Community Day is open to the public, providing the latest information on research, treatment, care and quality of life for persons with dementia and their care partners. Hosted at the Memorial Learning Center, attendees will have a chance to hear from medical professionals from the Dale and Deborah Smith Alzheimer's Center for Research and Treatment and other institutions, department leaders at SIU Medicine, as well as other caregivers. This year, we'll explore the "Roadmap for Brain Health," designed to provide you resources for the journey ahead in caring for
Events

Brain Aging Conference - Professionals Day

The Brain Aging Conference - Professionals Day provides health care professionals an opportunity to earn continuing education credits and learn about trends and research related to caring for those with Alzheimer’s and related disorders. From an overview about Alzheimer's, managing agitation and behavior changes, updates on research opportunities, and more, this conference is designed to help you provide better treatment and care for persons with memory loss and their caregivers. This conference is approved for a maximum of 6 AMA PRA Category 1 credits.
Events

Brain Aging Conference - Professionals Day 2023

The Brain Aging Conference - Professionals Day provides medical professionals an opportunity to earn continuing education credits and learn about trends and research related to caring for those with Alzheimer’s and related disorders. This conference is designed to help you provide a roadmap to patients and caregivers as they navigate their journey after a diagnosis. This conference is approved for a maximum of 7.25 AMA PRA Category 1 credits.